张述伟

个人信息Personal Information

教授

硕士生导师

性别:男

毕业院校:大连理工大学

学位:硕士

所在单位:化工学院

电子邮箱:zswei@dlut.edu.cn

扫描关注

论文成果

当前位置: 中文主页 >> 科学研究 >> 论文成果

A Computational Study on Thiourea Analogs as Potent MK-2 Inhibitors

点击次数:

论文类型:期刊论文

发表时间:2012-06-01

发表刊物:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

收录刊物:SCIE、PubMed、Scopus

卷号:13

期号:6

页面范围:7057-7079

ISSN号:1661-6596

关键字:3D-QSAR; molecular dynamics; MK-2 inhibitors; CoMFA; CoMSIA

摘要:Mitogen-activated protein kinase-activated protein kinase 2 (MK-2) has been identified as a drug target for the treatment of inflammatory diseases. Currently, a series of thiourea analogs as potent MK-2 inhibitors were studied using comprehensive computational methods by 3D-QSAR, molecular docking and molecular dynamics simulations for a further improvement in activities. The optimal 3D models exhibit high statistical significance of the results, especially for the CoMFA results with r(ncv)(2), q(2) values of 0.974, 0.536 for the internal validation, and r(pred)(2), r(m)(2) values of 0.910, 0.723 for the external validation and Roy's index, respectively. In addition, more rigorous validation criteria suggested by Tropsha were also employed to check the built models. Graphic representation of the results, as contoured 3D coefficient plots, also provides a clue to the reasonable modification of molecules: (i) The substituent with a bulky size and electron-rich group at the C5 position of the pyrazine ring is required to enhance the potency; (ii) The H-bond acceptor group in the C3 position of the pyrazine ring is likely to be helpful to increase MK-2 inhibition; (iii) The small and electropositive substituent as a hydrogen bond donor of the C2 position in the oxazolone ring is favored; In addition, several important amino acid residues were also identified as playing an important role in MK-2 inhibition. The agreement between 3D-QSAR, molecular docking and molecular dynamics simulations also proves the rationality of the developed models. These results, we hope, may be helpful in designing novel and potential MK-2 inhibitors.